US Bioservices & AdhereTech Collaborate to Improve Patient Adherence to Therapy

Patients using AdhereTech Smart Pill Bottles through US Bioservices
stayed on therapy longer, refilled prescriptions more frequently

CARROLLTON, Texas–(BUSINESS WIRE)–US Bioservices, a specialty pharmacy that is a part of
AmerisourceBergen, announced findings from an initial program with
AdhereTech. Based on the program’s successful results described below,
US Bioservices plans to extend the AdhereTech offering to larger patient
populations by including the Smart Pill Bottle in additional
manufacturer programs.

A provider of pharma-sponsored support programs for specialty
medications, AdhereTech develops patented Smart Pill Bottles for
manufacturers and pharmacies across the U.S. AdhereTech collaborated
with US Bioservices to analyze 18 months of fill-level data for patients
using the Smart Pill Bottles for their medications. The results showed
that patients new to therapy who began treatment with the Smart Pill
Bottle stayed on therapy for 1.5 additional months and had 1.3
additional fills dispensed. Consistently, patients continuing on a
therapy had 1.2 additional fills dispensed compared to their peers not
in the program.

“US Bioservices is committed to providing our patients with the highest
level of support so that they can achieve the best results from their
therapies. We know that adherence remains one of the most critical
challenges facing patients, and we are excited to expand access to a
data-backed solution that is directly correlated to more positive
outcomes,” said Angela Ward, President of US Bioservices. “This new
offering is aligned with our commitment to pushing the frontier of
support solutions to maximize benefits for patients, manufacturers and
providers alike.”

The AdhereTech Smart Pill Bottle is simple and seamless for patients to
use, requiring no additional costs or set up. The system analyzes data
and sends personalized messages to patients about missed doses and
upcoming refill reminders, via text message or phone call. AdhereTech’s
capabilities also include notifying a patient’s pharmacy in real-time if
the patient encounters a health or medication issue, enabling pharmacist
intervention sooner.

As an independent specialty pharmacy, US Bioservices is dedicated to
being a premier partner on programs that support patients with chronic
and complex conditions. By fostering long-standing, collaborative
relationships across the healthcare continuum, US Bioservices creates an
integrated care environment that benefits patients, prescribers and
caregivers. US Bioservices has been leveraging AdhereTech Smart Pill
Bottles since 2017.

Through the breadth of resources available at AmerisourceBergen, US
Bioservices develops solutions to ensure all patients on therapy receive
uncompromising support to navigate their treatment, clinically,
economically and socially.

About AmerisourceBergen

AmerisourceBergen provides pharmaceutical products, value-driving
services and business solutions that improve access to care. Tens of
thousands of healthcare providers, veterinary practices and livestock
producers trust us as their partner in the pharmaceutical supply chain.
Global manufacturers depend on us for services that drive commercial
success for their products. Through our daily work — and powered by our
21,000 associates — we are united in our responsibility to create
healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500,
with more than $160 billion in annual revenue. The company is
headquartered in Valley Forge, Pa. and has a presence in 50+ countries.
Learn more at amerisourcebergen.com.

About AdhereTech

AdhereTech is a software and data company that develops highly-effective
patient support programs, which are customized using real-time data from
our patented smart devices and other feeds. Customers include many of
the largest pharma companies and specialty medications, as well as most
of the top specialty pharmacies in the US. AdhereTech’s programs result
in patients staying on the medication longer, with increased adherence
while they are on therapy. This drives additional fills of medication
per patient per year, as compared to the baseline metrics. AdhereTech’s
mission is to improve the patient experience by building software and
devices that seamlessly connect patients to care. Learn more at www.adheretech.com.

Contacts

Francesca Gunning, AmerisourceBergen
610-727-7433 – Office
215-603-9264
– Mobile
[email protected]

Kate Kanaby, Tierney Communications
215-790-4169 – Office
908-328-6108
– Mobile
[email protected]